CN Stock MarketDetailed Quotes

688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Watchlist
  • 6.63
  • +0.13+2.00%
Market Closed Jul 19 15:00 CST
6.87BMarket Cap66.97P/E (TTM)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-21.94%147.65M
-17.50%850.73M
-1.16%707.96M
92.74%522.83M
34.33%189.15M
-9.57%1.03B
2.60%716.27M
-32.02%271.26M
11.57%140.81M
36.76%1.14B
Operating revenue
-21.94%147.65M
-17.50%850.73M
-1.16%707.96M
92.74%522.83M
34.33%189.15M
-9.57%1.03B
2.60%716.27M
-32.02%271.26M
11.57%140.81M
36.76%1.14B
Total operating cost
-12.60%145.21M
-18.27%742.53M
-10.13%600.14M
46.02%438.05M
12.03%166.15M
-6.12%908.47M
12.63%667.79M
-9.17%299.99M
17.78%148.31M
41.47%967.66M
Operating cost
-37.30%10.88M
-15.98%70.63M
-0.19%54.97M
47.73%41.58M
63.02%17.35M
3.84%84.06M
12.29%55.07M
11.06%28.14M
39.09%10.64M
24.91%80.96M
Operating tax surcharges
2.69%1.27M
-21.21%5.39M
-0.93%3.89M
-13.01%2.27M
-30.63%1.23M
11.26%6.84M
1.44%3.93M
18.96%2.61M
39.56%1.78M
50.56%6.15M
Operating expense
-28.45%59.71M
-30.84%383.59M
-13.07%333.64M
86.58%249.23M
3.11%83.44M
-7.51%554.63M
10.75%383.82M
-27.45%133.57M
24.77%80.93M
41.12%599.7M
Administration expense
9.10%10.98M
-4.48%42.86M
-29.03%39.08M
-21.45%27.45M
32.05%10.06M
-25.91%44.87M
44.73%55.06M
58.66%34.95M
7.20%7.62M
19.31%60.56M
Financial expense
-2,247.64%-1.23M
57.86%-3.7M
100.98%19.42K
76.83%-428.55K
95.22%-52.42K
-115.00%-8.79M
47.76%-1.99M
-9.92%-1.85M
-56.11%-1.1M
-3,276.11%-4.09M
-Interest expense (Financial expense)
-82.45%162.31K
99.33%3.07M
160.55%2.68M
145.42%1.82M
165.95%924.66K
45.79%1.54M
167.75%1.03M
85.69%742.39K
89.60%347.69K
-81.16%1.06M
-Interest Income (Financial expense)
-34.66%-1.41M
29.41%-7.97M
3.07%-3.85M
5.13%-2.34M
35.34%-1.05M
-119.96%-11.29M
-926.86%-3.97M
-13.84%-2.46M
-75.43%-1.62M
16.26%-5.13M
Research and development
17.54%63.62M
7.46%243.76M
-1.95%168.54M
15.01%117.95M
11.73%54.12M
1.10%226.85M
7.97%171.89M
4.37%102.56M
5.94%48.44M
61.12%224.39M
Credit Impairment Loss
77.06%-5.56M
-1,102.93%-24.2M
-36.45%-30.93M
28.77%-28.55M
-833.59%-24.23M
328.24%2.41M
-411.51%-22.67M
-239.53%-40.09M
183.91%3.3M
104.60%563.36K
Asset Impairment Loss
88.91%-116.02K
-187.58%-8.45M
47.37%-2.25M
-18,392.84%-1.28M
-1,687.54%-1.05M
-4,356.07%-2.94M
---4.27M
--7K
--65.92K
94.83%-65.92K
Other net revenue
Invest income
-39.44%1.08M
-238.31%-4.35M
-50.82%2.64M
-51.55%2.85M
18.02%1.78M
-106.19%-1.28M
-47.18%5.36M
-35.12%5.88M
-72.99%1.51M
20.47%20.76M
-Including: Investment income associates
-11.38%-3.47M
-15.39%-23.54M
-42.87%-12.38M
-99.42%-7.43M
-13.58%-3.12M
-1,173.21%-20.4M
-57.59%-8.67M
-31.48%-3.72M
-221.70%-2.75M
38.83%-1.6M
Asset deal income
-83.20%127.99K
-84.63%295.35K
-6.32%1.29M
139.32%1.47M
197.60%761.95K
7.68%1.92M
27.99%1.38M
1.37%615.68K
50.76%256.03K
-61.20%1.78M
Other revenue
0.16%3.22M
144.43%25.58M
123.58%5.55M
160.48%4.02M
268.28%3.22M
-51.74%10.47M
-36.76%2.48M
-18.19%1.54M
-11.35%873.48K
45.28%21.69M
Operating profit
-65.82%1.19M
-27.15%97.09M
173.49%84.12M
204.13%63.28M
333.30%3.48M
-38.69%133.27M
-73.46%30.76M
-188.69%-60.77M
-148.11%-1.49M
25.63%217.38M
Add:Non operating Income
42.52%293.22K
51.69%1.3M
3.68%626.5K
6.15%424.26K
-5.60%205.74K
1.01%854.05K
-5.01%604.25K
-4.57%399.69K
9.35%217.93K
-82.00%845.52K
Less:Non operating expense
-89.83%153.99K
-53.21%857.08K
-40.10%833.69K
-66.50%273.83K
96.29%1.51M
-20.43%1.83M
-35.81%1.39M
-61.99%817.4K
-37.98%771.47K
124.14%2.3M
Total profit
-38.83%1.33M
-26.28%97.53M
179.98%83.91M
203.67%63.43M
206.22%2.17M
-38.73%132.29M
-73.80%29.97M
-191.62%-61.19M
-199.46%-2.05M
22.20%215.92M
Less:Income tax cost
85.94%-930.61K
-119.37%-10.92M
12.82%-5.9M
79.45%-5.17M
3.42%-6.62M
-240.63%-4.98M
-90.17%-6.77M
-1,565.52%-25.17M
-135.73%-6.86M
-71.55%3.54M
Net profit
-74.30%2.26M
-21.00%108.45M
144.45%89.81M
FLtoP68.6M
82.83%8.79M
-35.37%137.27M
-68.85%36.74M
SL-36.02M
-3.13%4.81M
29.30%212.38M
Net profit from continuing operation
-74.30%2.26M
-21.00%108.45M
144.45%89.81M
290.46%68.6M
82.83%8.79M
-35.37%137.27M
-68.85%36.74M
-155.36%-36.02M
-3.13%4.81M
29.30%212.38M
Less:Minority Profit
-1,356.54%-87.52K
75.51%-177.51K
4.23%-80.34K
460.98%167.26K
106.01%6.97K
20.78%-724.9K
87.80%-83.89K
88.86%-46.34K
23.68%-115.88K
-126.78%-915.05K
Net profit of parent company owners
-73.29%2.35M
-21.28%108.63M
144.11%89.89M
290.24%68.44M
78.39%8.79M
-35.30%138M
-68.95%36.82M
-154.94%-35.97M
-3.74%4.93M
29.53%213.3M
Earning per share
Basic earning per share
--0
-15.38%0.11
125.00%0.09
333.33%0.07
--0.01
-38.10%0.13
-63.64%0.04
-150.00%-0.03
--0
23.53%0.21
Diluted earning per share
--0
-15.38%0.11
125.00%0.09
333.33%0.07
--0.01
-35.00%0.13
-63.64%0.04
-150.00%-0.03
--0
17.65%0.2
Other composite income
108.95%30.88K
42.85%-657.35K
86.32%-164.8K
84.75%-107.59K
25.33%-345.11K
64.93%-1.15M
31.61%-1.2M
-117.88%-705.63K
-123.47%-462.15K
-165.23%-3.28M
Other composite income of parent company owners
108.95%30.88K
----
86.32%-164.8K
----
25.33%-345.11K
----
31.61%-1.2M
----
-123.47%-462.15K
----
Total composite income
-72.89%2.29M
-20.81%107.79M
152.27%89.65M
286.51%68.5M
94.33%8.45M
-34.90%136.12M
-69.41%35.54M
-153.21%-36.73M
-37.30%4.35M
23.52%209.1M
Total composite income of parent company owners
-71.83%2.38M
-21.10%107.97M
151.90%89.73M
286.29%68.33M
89.12%8.44M
-34.84%136.85M
-69.52%35.62M
-152.83%-36.68M
-37.01%4.46M
23.76%210.02M
Total composite income of minority owners
-1,356.54%-87.52K
75.51%-177.51K
4.23%-80.34K
460.98%167.26K
106.01%6.97K
20.78%-724.9K
87.80%-83.89K
88.86%-46.34K
23.68%-115.88K
-126.78%-915.05K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -21.94%147.65M-17.50%850.73M-1.16%707.96M92.74%522.83M34.33%189.15M-9.57%1.03B2.60%716.27M-32.02%271.26M11.57%140.81M36.76%1.14B
Operating revenue -21.94%147.65M-17.50%850.73M-1.16%707.96M92.74%522.83M34.33%189.15M-9.57%1.03B2.60%716.27M-32.02%271.26M11.57%140.81M36.76%1.14B
Total operating cost -12.60%145.21M-18.27%742.53M-10.13%600.14M46.02%438.05M12.03%166.15M-6.12%908.47M12.63%667.79M-9.17%299.99M17.78%148.31M41.47%967.66M
Operating cost -37.30%10.88M-15.98%70.63M-0.19%54.97M47.73%41.58M63.02%17.35M3.84%84.06M12.29%55.07M11.06%28.14M39.09%10.64M24.91%80.96M
Operating tax surcharges 2.69%1.27M-21.21%5.39M-0.93%3.89M-13.01%2.27M-30.63%1.23M11.26%6.84M1.44%3.93M18.96%2.61M39.56%1.78M50.56%6.15M
Operating expense -28.45%59.71M-30.84%383.59M-13.07%333.64M86.58%249.23M3.11%83.44M-7.51%554.63M10.75%383.82M-27.45%133.57M24.77%80.93M41.12%599.7M
Administration expense 9.10%10.98M-4.48%42.86M-29.03%39.08M-21.45%27.45M32.05%10.06M-25.91%44.87M44.73%55.06M58.66%34.95M7.20%7.62M19.31%60.56M
Financial expense -2,247.64%-1.23M57.86%-3.7M100.98%19.42K76.83%-428.55K95.22%-52.42K-115.00%-8.79M47.76%-1.99M-9.92%-1.85M-56.11%-1.1M-3,276.11%-4.09M
-Interest expense (Financial expense) -82.45%162.31K99.33%3.07M160.55%2.68M145.42%1.82M165.95%924.66K45.79%1.54M167.75%1.03M85.69%742.39K89.60%347.69K-81.16%1.06M
-Interest Income (Financial expense) -34.66%-1.41M29.41%-7.97M3.07%-3.85M5.13%-2.34M35.34%-1.05M-119.96%-11.29M-926.86%-3.97M-13.84%-2.46M-75.43%-1.62M16.26%-5.13M
Research and development 17.54%63.62M7.46%243.76M-1.95%168.54M15.01%117.95M11.73%54.12M1.10%226.85M7.97%171.89M4.37%102.56M5.94%48.44M61.12%224.39M
Credit Impairment Loss 77.06%-5.56M-1,102.93%-24.2M-36.45%-30.93M28.77%-28.55M-833.59%-24.23M328.24%2.41M-411.51%-22.67M-239.53%-40.09M183.91%3.3M104.60%563.36K
Asset Impairment Loss 88.91%-116.02K-187.58%-8.45M47.37%-2.25M-18,392.84%-1.28M-1,687.54%-1.05M-4,356.07%-2.94M---4.27M--7K--65.92K94.83%-65.92K
Other net revenue
Invest income -39.44%1.08M-238.31%-4.35M-50.82%2.64M-51.55%2.85M18.02%1.78M-106.19%-1.28M-47.18%5.36M-35.12%5.88M-72.99%1.51M20.47%20.76M
-Including: Investment income associates -11.38%-3.47M-15.39%-23.54M-42.87%-12.38M-99.42%-7.43M-13.58%-3.12M-1,173.21%-20.4M-57.59%-8.67M-31.48%-3.72M-221.70%-2.75M38.83%-1.6M
Asset deal income -83.20%127.99K-84.63%295.35K-6.32%1.29M139.32%1.47M197.60%761.95K7.68%1.92M27.99%1.38M1.37%615.68K50.76%256.03K-61.20%1.78M
Other revenue 0.16%3.22M144.43%25.58M123.58%5.55M160.48%4.02M268.28%3.22M-51.74%10.47M-36.76%2.48M-18.19%1.54M-11.35%873.48K45.28%21.69M
Operating profit -65.82%1.19M-27.15%97.09M173.49%84.12M204.13%63.28M333.30%3.48M-38.69%133.27M-73.46%30.76M-188.69%-60.77M-148.11%-1.49M25.63%217.38M
Add:Non operating Income 42.52%293.22K51.69%1.3M3.68%626.5K6.15%424.26K-5.60%205.74K1.01%854.05K-5.01%604.25K-4.57%399.69K9.35%217.93K-82.00%845.52K
Less:Non operating expense -89.83%153.99K-53.21%857.08K-40.10%833.69K-66.50%273.83K96.29%1.51M-20.43%1.83M-35.81%1.39M-61.99%817.4K-37.98%771.47K124.14%2.3M
Total profit -38.83%1.33M-26.28%97.53M179.98%83.91M203.67%63.43M206.22%2.17M-38.73%132.29M-73.80%29.97M-191.62%-61.19M-199.46%-2.05M22.20%215.92M
Less:Income tax cost 85.94%-930.61K-119.37%-10.92M12.82%-5.9M79.45%-5.17M3.42%-6.62M-240.63%-4.98M-90.17%-6.77M-1,565.52%-25.17M-135.73%-6.86M-71.55%3.54M
Net profit -74.30%2.26M-21.00%108.45M144.45%89.81MFLtoP68.6M82.83%8.79M-35.37%137.27M-68.85%36.74MSL-36.02M-3.13%4.81M29.30%212.38M
Net profit from continuing operation -74.30%2.26M-21.00%108.45M144.45%89.81M290.46%68.6M82.83%8.79M-35.37%137.27M-68.85%36.74M-155.36%-36.02M-3.13%4.81M29.30%212.38M
Less:Minority Profit -1,356.54%-87.52K75.51%-177.51K4.23%-80.34K460.98%167.26K106.01%6.97K20.78%-724.9K87.80%-83.89K88.86%-46.34K23.68%-115.88K-126.78%-915.05K
Net profit of parent company owners -73.29%2.35M-21.28%108.63M144.11%89.89M290.24%68.44M78.39%8.79M-35.30%138M-68.95%36.82M-154.94%-35.97M-3.74%4.93M29.53%213.3M
Earning per share
Basic earning per share --0-15.38%0.11125.00%0.09333.33%0.07--0.01-38.10%0.13-63.64%0.04-150.00%-0.03--023.53%0.21
Diluted earning per share --0-15.38%0.11125.00%0.09333.33%0.07--0.01-35.00%0.13-63.64%0.04-150.00%-0.03--017.65%0.2
Other composite income 108.95%30.88K42.85%-657.35K86.32%-164.8K84.75%-107.59K25.33%-345.11K64.93%-1.15M31.61%-1.2M-117.88%-705.63K-123.47%-462.15K-165.23%-3.28M
Other composite income of parent company owners 108.95%30.88K----86.32%-164.8K----25.33%-345.11K----31.61%-1.2M-----123.47%-462.15K----
Total composite income -72.89%2.29M-20.81%107.79M152.27%89.65M286.51%68.5M94.33%8.45M-34.90%136.12M-69.41%35.54M-153.21%-36.73M-37.30%4.35M23.52%209.1M
Total composite income of parent company owners -71.83%2.38M-21.10%107.97M151.90%89.73M286.29%68.33M89.12%8.44M-34.84%136.85M-69.52%35.62M-152.83%-36.68M-37.01%4.46M23.76%210.02M
Total composite income of minority owners -1,356.54%-87.52K75.51%-177.51K4.23%-80.34K460.98%167.26K106.01%6.97K20.78%-724.9K87.80%-83.89K88.86%-46.34K23.68%-115.88K-126.78%-915.05K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg